Jubilant Pharmova Limited
NSE:JUBLPHARMA.NS
1239 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 67,029 | 62,193 | 60,591.65 | 59,638.76 | 89,765.37 | 89,970.88 | 74,247.76 | 57,652.75 | 57,004.5 | 57,761.38 | 57,216.13 | 51,429.9 | 43,031.26 | 34,334.04 | 37,812.72 | 35,179.84 | 24,888.77 | 18,097.15 | 15,053.5 | 11,702.65 | 8,592.01 |
Kosten van de omzet
| 47,386 | 18,779.3 | 17,869.88 | 17,534.52 | 34,544.7 | 38,212.55 | 31,435.19 | 22,521.69 | 23,708.8 | 29,184.56 | 26,869.98 | 20,500.46 | 22,317.56 | 13,695.01 | 30,458.07 | 16,395.26 | 11,691.53 | 9,689.35 | 12,883.04 | 6,611.87 | 4,379.41 |
Brutowinst
| 19,643 | 43,413.7 | 42,721.77 | 42,104.24 | 55,220.67 | 51,758.33 | 42,812.57 | 35,131.06 | 33,295.7 | 28,576.82 | 30,346.15 | 30,929.44 | 20,713.7 | 20,639.03 | 7,354.65 | 18,784.58 | 13,197.24 | 8,407.8 | 2,170.46 | 5,090.78 | 4,212.6 |
Brutowinstmarge
| 0.293 | 0.698 | 0.705 | 0.706 | 0.615 | 0.575 | 0.577 | 0.609 | 0.584 | 0.495 | 0.53 | 0.601 | 0.481 | 0.601 | 0.195 | 0.534 | 0.53 | 0.465 | 0.144 | 0.435 | 0.49 |
Onderzoek- en ontwikkelingskosten
| 148 | 0 | 0 | 0 | 185.05 | 202.2 | 182.05 | 161.64 | 131.16 | 71.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 22,209 | 2,230.78 | 2,457.96 | 2,322.6 | 2,464.69 | 2,675.91 | 1,459.12 | 1,023.26 | 971.38 | 1,235.83 | 1,056.4 | 7,636.55 | 1,917.34 | 3,674.65 | 0 | 4,223.55 | 3,344.07 | 2,701.74 | 0 | 1,863.6 | 1,462.94 |
Verkoop- en marketingkosten
| 664 | 1,526.51 | 1,559.24 | 1,490.51 | 2,318.88 | 2,176.8 | 1,957.95 | 1,331.63 | 1,202.87 | 1,283.7 | 1,608.89 | 1,232.82 | 1,120.97 | 1,624.31 | 0 | 1,177.72 | 948.66 | 785.09 | 0 | 467.81 | 319.33 |
Verkoop-, algemene en administratieve kosten
| 14,454 | 3,757.29 | 4,017.2 | 3,813.11 | 4,783.57 | 4,852.71 | 3,417.07 | 2,354.89 | 2,174.25 | 2,519.53 | 2,665.29 | 8,869.37 | 3,038.31 | 5,298.96 | 0 | 5,401.27 | 4,292.73 | 3,486.83 | 0 | 2,331.41 | 1,782.27 |
Overige kosten
| 687 | 383.3 | 86.9 | 67.18 | 115.14 | 125.48 | 226.88 | 159.32 | 109.04 | 134.08 | 113.58 | 175.45 | -39.53 | 11,595.47 | 670.48 | 7,885.88 | 3,999.22 | 2,567.82 | 316.41 | 1,316.53 | 1,120.12 |
Bedrijfskosten
| 14,454 | 41,191.5 | 34,477.26 | 30,917.52 | 40,341.51 | 37,937.82 | 31,738.15 | 24,398.27 | 23,888.08 | 24,552.57 | 23,065.56 | 22,830.68 | 13,841.14 | 16,894.43 | 670.48 | 13,287.15 | 8,291.95 | 6,054.65 | 316.41 | 3,647.94 | 2,902.39 |
Bedrijfsresultaat
| 5,189 | 3,748.77 | 8,398.34 | 11,442.53 | 12,387.29 | 13,820.51 | 11,074.42 | 10,732.79 | 9,407.62 | 4,024.25 | 7,280.59 | 8,098.76 | 6,872.56 | 3,744.6 | 6,684.17 | 5,497.43 | 4,905.29 | 2,353.15 | 1,854.05 | 1,442.84 | 1,310.21 |
Bedrijfsresultaat ratio
| 0.077 | 0.06 | 0.139 | 0.192 | 0.138 | 0.154 | 0.149 | 0.186 | 0.165 | 0.07 | 0.127 | 0.157 | 0.16 | 0.109 | 0.177 | 0.156 | 0.197 | 0.13 | 0.123 | 0.123 | 0.152 |
Totaal overige inkomsten en kosten netto
| -3,725 | -3,470.96 | -2,093.87 | -2,731.77 | -2,258.54 | -4,782.4 | -2,483.6 | -3,356.37 | -3,564.24 | -3,621.01 | -5,207.76 | -4,687.38 | -5,731.49 | -1,338.69 | -1,505.2 | -2,531.67 | -343.98 | 599.89 | -172.66 | 198.4 | -343.93 |
Inkomen voor belasting
| 1,464 | 277.8 | 6,304.47 | 8,710.76 | 12,105.31 | 9,038.11 | 8,590.82 | 7,376.42 | 5,843.38 | 403.24 | 2,072.83 | 3,411.38 | 1,141.07 | 2,405.91 | 5,178.97 | 2,965.76 | 4,561.31 | 2,953.04 | 1,681.39 | 1,641.24 | 966.28 |
Inkomen voor belasting ratio
| 0.022 | 0.004 | 0.104 | 0.146 | 0.135 | 0.1 | 0.116 | 0.128 | 0.103 | 0.007 | 0.036 | 0.066 | 0.027 | 0.07 | 0.137 | 0.084 | 0.183 | 0.163 | 0.112 | 0.14 | 0.112 |
Belastingkosten
| 978 | 926.6 | 2,174.31 | 2,972.18 | 3,122.88 | 3,268.03 | 2,246.64 | 1,630.16 | 1,528.53 | 804.84 | 696.44 | 1,523.6 | 684.14 | 133.65 | 959.44 | -267.19 | -572.84 | -712.49 | 392.44 | -431.59 | -179 |
Nettowinst
| 771 | -609.8 | 4,139.36 | 8,358.69 | 8,982.46 | 5,744.56 | 6,428.06 | 5,756.53 | 4,314.85 | -577.64 | 1,090.4 | 1,527.27 | 145.61 | 2,297.19 | 4,214.61 | 2,831.76 | 4,004.94 | 2,280 | 1,296.75 | 1,191.93 | 782.37 |
Nettowinstmarge
| 0.012 | -0.01 | 0.068 | 0.14 | 0.1 | 0.064 | 0.087 | 0.1 | 0.076 | -0.01 | 0.019 | 0.03 | 0.003 | 0.067 | 0.111 | 0.08 | 0.161 | 0.126 | 0.086 | 0.102 | 0.091 |
WPA (Winst Per Aandeel)
| 4.87 | -3.83 | 26.01 | 52.48 | 56.39 | 36.1 | 41.25 | 36.93 | 25.1 | -3.63 | 6.85 | 9.59 | 0.91 | 14.42 | 28.56 | 18.3 | 26.5 | 15.17 | 9.03 | 9.41 | 6.35 |
Verwaterde WPA
| 4.86 | -3.83 | 26.01 | 52.48 | 56.39 | 36.1 | 41.25 | 36.91 | 25.08 | -3.63 | 6.85 | 9.59 | 0.91 | 13.04 | 24.66 | 15.77 | 21.35 | 12.4 | 8.16 | 8.9 | 6.35 |
EBITDA
| 9,008 | 8,268.3 | 11,536.15 | 15,211.8 | 19,825.77 | 17,749.03 | 15,328.78 | 13,362.22 | 12,642.07 | 6,823.56 | 10,084.99 | 10,605.72 | 9,444.59 | 5,385.42 | 7,931.01 | 7,072.86 | 6,408.72 | 2,944.33 | 2,390.91 | 1,816.29 | 1,624.38 |
EBITDA ratio
| 0.134 | 0.133 | 0.19 | 0.255 | 0.221 | 0.197 | 0.206 | 0.232 | 0.222 | 0.118 | 0.176 | 0.206 | 0.219 | 0.157 | 0.21 | 0.201 | 0.257 | 0.163 | 0.159 | 0.155 | 0.189 |